Synapse - Gregory Riely

Results (219)

KRAS mutational testing in the selection of patients for EGFR-targeted therapies

Journal Article

Garcia, J.; Riely, G. J.; Nafa, K.; Ladanyi, M.
Seminars in Diagnostic Pathology (2008)

Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma

Journal Article

Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
Clinical Cancer Research (2008)

Fulltext@MSK | Save

Smoking history and frequency of somatic KRAS mutations in adenocarcinoma of the lung

Meeting Abstract

Miller, V. A.; Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D.; Nafa, K.; Pao, W.; Ladanyi, M.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression

Meeting Abstract

Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
Journal of Molecular Diagnostics (2007)

Fulltext@MSK | Save

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Meeting Abstract

Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Journal Article

Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
Proceedings of the National Academy of Sciences of the United States of America (2007)

Fulltext@MSK | Save

Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer

Meeting Abstract

Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
Cancer Research (2006)

Fulltext@MSK | Save

Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib

Meeting Abstract

Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial

Meeting Abstract

Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Ladanyi, M.; Tsao, A. S.; Sandler, A.; Herbst, R.; Kris, M. G.; Johnson, D. H.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type

Meeting Abstract

Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
Modern Pathology (2006)

Fulltext@MSK | Save

Gregory J Riely

Results (219)

Journal Article

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract